| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-07 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.28 | 4e-07 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.21 | 1e-06 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.14 | 2e-06 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.14 | 8e-06 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.14 | 1e-05 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.13 | 3e-05 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-05 |